![]() |
市場調查報告書
商品編碼
1800881
螢光原位雜合技術探針市場報告(按類型、探針類型、技術、應用、最終用戶和地區)2025-2033Fluorescent in Situ Hybridization Probe Market Report by Type, Probe Type, Technology, Application, End-User, and Region 2025-2033 |
2024年,全球螢光原位雜合技術 (FISH) 探針市場規模達9.262億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到15.796億美元,2025-2033年期間的複合年成長率 (CAGR) 為5.81%。遺傳性疾病盛行率的不斷上升、對早期疾病檢測和篩檢的日益重視以及廣泛的研發活動是推動市場發展的主要因素。
螢光原位雜合技術 (FISH) 探針是一種分子生物學技術,用於可視化和定位細胞和組織內特定的脫氧核糖核酸 (DNA) 或核糖核酸 (RNA) 序列。它們由各種材料組成,例如寡核苷酸、螢光團、連接子和間隔子、封閉劑和雜交緩衝液。 FISH 探針廣泛應用於染色體異常檢測、基因拷貝數變異分析、腫瘤學研究、微生物鑑定、基因表現分析和產前診斷。它們具有高靈敏度和解析度,甚至可以檢測低拷貝數的目標序列。
個人化醫療需求的不斷成長促進了 FISH 探針的應用,因為它們能夠提供關於個別患者基因圖譜的寶貴資訊,從而根據患者特定的基因變異制定個性化治療策略。此外,臨床醫生和研究人員廣泛使用 FISH 探針來獲取關於基因異常的高解析度可視化和定量資訊,這為市場成長提供了動力。此外,多國政府推出的支持性政策,為患者報銷高級診斷檢測費用並提供高品質的醫療服務,也正在增強市場成長。其他因素,包括老年人口的成長、醫療保健行業的快速擴張、廣泛的研發 (R&D) 活動、對標靶治療的日益關注以及對高級 FISH 探針開發投資的增加,預計將推動市場成長。
遺傳疾病的盛行率不斷上升
FISH探針廣泛用於檢測與遺傳疾病相關的結構異常,例如缺失、重複、倒位和易位。此外,它們在診斷標準顯微鏡下極難檢測到的微缺失和微重複症候群方面發揮著至關重要的作用。此外,FISH探針能夠檢測重複擴增,有助於識別亨廷頓氏舞蹈症、脆性X症候群和強直性肌肉營養不良症。此外,它們還可以評估基因拷貝數變化,從而幫助醫療保健專業人員進行疾病分類、預測治療反應並指導個人化治療決策,從而促進市場成長。此外,FISH探針還可以提供有關攜帶者狀態的資訊,使個人能夠做出明智的生育決策並獲得適當的遺傳諮詢。
越來越重視早期疾病檢測和篩檢
FISH 探針在早期癌症檢測和診斷中發揮著至關重要的作用,因為它們可以針對各種癌症中常見的特定基因變異,包括基因擴增、缺失、易位和染色體重排。此外,它們還可用於早期診斷由寄生蟲、細菌或病毒引起的傳染病。此外,FISH 探針也廣泛用於及時檢測遺傳疾病,例如唐氏症、特納氏症或杜氏肌肉營養不良症。此外,它們還廣泛用於產前診斷,以檢測發育中胎兒的染色體異常,幫助父母就懷孕和潛在的醫療干預做出明智的決定。
廣泛的研發活動
多重 FISH 探針的引入,使得研究人員和臨床醫生能夠在單一樣本中同時檢測多個基因靶點,從而節省時間和資源,對市場成長產生了積極影響。此外,近期開發的近距離 FISH 探針能夠檢測細胞或組織樣本中兩個或多個基因靶點之間的空間接近度,從而提供有關細胞內空間相互作用、基因聚集和染色質組織的寶貴資訊,這也促進了市場成長。此外,FISH 探針資料的快速數位化,使得資料共享和影像分析、儲存和遠端存取自動化,也為市場成長提供了支援。
The global fluorescent in situ hybridization (FISH) probe market size reached USD 926.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,579.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.81% during 2025-2033. The increasing prevalence of genetic disorders, growing emphasis on early disease detection and screening, and extensive research and development (R&D) activities are some of the major factors propelling the market.
Fluorescent in situ hybridization (FISH) probe is a molecular biology technique used to visualize and map specific deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequences within cells and tissues. They are composed of various materials, such as oligonucleotides, fluorophores, linkers and spacers, blocking reagents, and hybridization buffers. FISH probes are widely used in chromosomal abnormality detection, gene copy number variation analysis, oncology research, microbial identification, gene expression analysis, and prenatal diagnosis. They offer high sensitivity and resolution, allowing for the detection of even low-copy-number target sequences.
The increasing demand for personalized medicine is facilitating the adoption of FISH probes, as they provide valuable insights into individual patients' genetic profiles, enabling tailored treatment strategies based on their specific genetic alterations. Furthermore, the widespread utilization of FISH probes by clinicians and researchers to provide high-resolution visual and quantitative information about genetic abnormalities is providing an impetus to the market growth. Additionally, the implementation of supportive policies by several governments to reimburse patients for advanced diagnostic tests and provide access to high-quality healthcare facilities is strengthening the market growth. Other factors, including the rising geriatric population, the rapid expansion of the healthcare industry, extensive research and development (R&D) activities, rising focus on targeted therapies and increasing investment in the development of advanced FISH probes, are anticipated to drive the market growth.
The increasing prevalence of genetic disorders
FISH probes are extensively used to detect structural abnormalities associated with genetic disorders, such as deletions, duplications, inversions, and translocations. Furthermore, they play a crucial role in the diagnosis of microdeletion and microduplication syndromes that are extremely difficult to detect under a standard microscope. Moreover, FISH probes enable the detection of repeat expansions, which aids in identifying Huntington's disease, fragile X syndrome, and myotonic dystrophy. Apart from this, they allow the assessment of gene copy number changes, thus aiding healthcare professionals in disease classification, predicting treatment response, and guiding personalized therapy decisions, which in turn is contributing to the market growth. Additionally, FISH probes provide information about carrier status, which allow individuals to make informed reproductive decisions and receive appropriate genetic counseling.
The growing emphasis on early disease detection and screening
FISH probes play a critical role in early cancer detection and diagnosis, as they can target specific genetic alterations commonly found in various cancers, including gene amplifications, deletions, translocations, and chromosomal rearrangements. Apart from this, they find applications in early diagnosis of infectious diseases caused by parasites, bacteria, or viruses. Moreover, FISH probes are extensively used in the timely detection of genetic conditions, such as Down syndrome, Turner syndrome, or Duchenne muscular dystrophy. Additionally, they are widely employed in prenatal diagnosis to detect chromosomal abnormalities in developing fetuses, which allows parents to make informed decisions about pregnancy and potential medical interventions.
Extensive research and development (R&D) activities
The introduction of multiplex FISH Probes, which allows the simultaneous detection of multiple genetic targets within a single sample, enabling researchers and clinicians to analyze multiple genomic regions in a single experiment, thus saving time and resources, is positively influencing the market growth. Furthermore, the recent development of proximity-FISH probes that enables the detection of spatial proximity between two or more genetic targets within a cell or tissue sample, thus providing valuable information about spatial interactions, gene clustering, and chromatin organization within cells, is contributing to the market growth. Moreover, the rapid digitalization of FISH Probe data, allowing for enhanced data sharing and automated image analysis, storage, and remote access, is supporting the market growth.
RNA dominates the market
RNA is dominating the market, as RNA FISH probes enable researchers to investigate gene expression patterns at the single-cell level, which provides valuable insights into cellular heterogeneity, developmental processes, and disease mechanisms. Furthermore, they enable the detection and visualization of non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), which aids in improving the understanding of the functions and regulatory networks of these important RNA molecules. Apart from this, RNA FISH Probes facilitate the real-time observation and tracking of RNA dynamics, such as RNA synthesis, degradation, and turnover rates, thus enabling researchers to study RNA biology and cellular response. Moreover, they offer high sensitivity and specificity in detecting RNA molecules by reducing background noise and false-positive signals.
Locus specific probes hold the largest share in the market
Locus-specific probes are designed to hybridize to specific genetic loci or regions of interest in the genome, which allows researchers and clinicians to focus on specific genes and chromosomal abnormalities associated with particular diseases and conditions. They also offer high diagnostic accuracy and precision by enabling the detection of specific genetic abnormalities with great specificity. Apart from this, Locus-specific probes are extensively used to detect and characterize genetic variations in patients, including chromosomal aberrations, microdeletions, and gene mutations.
Flow FISH dominates the market
Flow FISH is dominating the market as it allows for rapid processing of a large number of cells, thus offering more data in a shorter amount of time compared to traditional FISH methods. Furthermore, it is known for its high sensitivity, which makes it ideal for detecting even low-abundance targets in medical diagnostics and research. In addition, flow FISH can be easily integrated with automation technologies to reduce manual errors and increase the throughput. Besides this, it provides quantitative data, which is crucial in fields such as healthcare, where precise measurements are required for diagnosis and treatment plans. Moreover, the cost per sample in flow FISH is less than traditional FISH methods, especially when analyzing large samples, making it highly appealing for both research and clinical settings.
Cancer dominates the market
FISH probes are widely used in cancer treatment as they help to detect specific genetic abnormalities. It also enables healthcare professionals to identify and classify cancer cells, which further assist in diagnosis, prognosis, and treatment decision-making. Furthermore, they offer high specificity and sensitivity in detecting genetic aberrations and chromosomal rearrangements that are characteristic of various types of cancer. Apart from this, FISH probes aid oncologists in selecting the most appropriate targeted therapies and monitoring treatment response. They also assist in cancer research by improving the understanding of the underlying mechanism associated with cancer. Additionally, FISH probes are widely used in liquid biopsies to offer a non-invasive approach for cancer detection, monitoring, and treatment response assessment.
FISH probes are widely used in research organizations to enable the visualization and detection of specific DNA or RNA sequences within cells or tissues. They are used in gene mapping and chromosomal analysis, which aids in studying cancer genetics and identifying chromosomal rearrangements associated with specific malignancies. Furthermore, the FISH probe is extensively utilized in developmental biology and neurobiology to provide valuable insights into gene regulation, cellular development, and disease mechanisms.
Diagnostic centers extensively utilize FISH probes to identify genetic alterations in patient samples, which aids in diagnosing cancer, determining prognosis, and guiding treatment decisions. They also assist in genetic disease screening by detecting specific genetic abnormalities, such as aneuploidies and microdeletion syndromes. Apart from this, FISH probes are widely used in prenatal testing to screen for chromosomal abnormalities in developing fetuses.
North America exhibits a clear dominance in the market, accounting for the largest fluorescent in situ hybridization (FISH) probe market share
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest market segment.
North America is dominating the FISH probe market owing to the strong focus on biomedical research in the region aimed at developing new diagnostic tools and molecular technologies. Additionally, the presence of a robust healthcare infrastructure comprising well-established hospitals, clinical laboratories, and diagnostic facilities is favoring the market growth. Moreover, the growing incidences of genetic disorders and cancer are facilitating the demand for accurate and reliable molecular diagnostic tools, such as FISH probes. Furthermore, the implementation of strict policies by regional governments to maintain the safety, efficacy, and quality of medical products and instruments is contributing to the market growth. Along with this, the presence of key players in the region that are equipped with resources and expertise to drive product development, marketing, and sales is positively influencing the market growth.
The top companies in the FISH probe market are actively engaged in developing new products by incorporating advanced technologies to improve the accuracy and reliability of results. In line with this, the significant investment in research and development (R&D) projects to expand their portfolio, gain competitive advantages, and meet rising consumer demand is favoring the market growth. Furthermore, several key players are adopting targeted marketing strategies by designing customized products that meet the unique requirements of users. Additionally, the increasing collaboration between leading companies, research institutions, and academic centers to jointly develop new FISH probe technologies, validate products through clinical studies, and strengthen market presence is contributing to the market growth. Moreover, several product manufacturers are establishing distribution channels, partnerships, and subsidiaries across the globe to expand their business and attract a new customer base.